Can we avoid the toxicity of chemotherapy in elderly cancer patients?

被引:25
|
作者
Feliu, Jaime [1 ]
Heredia-Soto, Victoria [1 ]
Girones, Regina [2 ]
Jimenez-Munarriz, Beatriz [3 ]
Saldana, Juana [4 ]
Guillen-Ponce, Carmen [5 ]
Molina-Garrido, M. J. [6 ]
机构
[1] Hosp Univ La Paz, Dept Med Oncol, CIBERONC, Madrid, Spain
[2] Hosp Lluis Alcanyis, Dept Med Oncol, Valencia, Spain
[3] Hosp Univ Clara Campal, Dept Med Oncol, Madrid, Spain
[4] Inst Catalan Oncol, Dept Med Oncol, Barcelona, Spain
[5] Hosp Univ Ramon & Cajal, Dept Med Oncol, Madrid, Spain
[6] Hosp Virgen de la Luz, Dept Med Oncol, Cuenca, Spain
关键词
Cancer; Elderly; Chemotherapy; Risk score; Toxicity; Geriatric assessment; COMPREHENSIVE GERIATRIC ASSESSMENT; CELL LUNG-CANCER; OLDER PATIENTS; INTERNATIONAL-SOCIETY; TREATMENT DECISIONS; COLORECTAL-CANCER; FUNCTIONAL STATUS; PROSTATE-CANCER; CLINICAL-TRIALS; WEIGHT-LOSS;
D O I
10.1016/j.critrevonc.2018.08.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although approximately 50% of cancer patients are 70 years of age or older, cancer treatment in the elderly remains a therapeutic challenge. The elderly form a very heterogeneous group in relation to their general health state, degree of dependence, comorbidities, performance status, physical reserve and geriatric situation, for which therapeutic decisions must be made in an individualized manner. In addition, changes in pharmacokinetics and pharmacodynamics of the drugs occur with age, as well as the tolerance of the tissues, leading to a narrowing of the therapeutic margin and an increase in toxicity. In the general population, Performace Status (PS) has traditionally been used to estimate tolerance to chemotherapy, but in the elderly population it is not useful. In this review we summarize the current knowledge about the pharmacology of antineoplastic drugs in the elderly and the tools available to help us identify risk of chemotherapy toxicity in these patients.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
  • [1] Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?
    Jesse Caron
    Anju Nohria
    [J]. Current Oncology Reports, 2018, 20
  • [2] Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?
    Caron, Jesse
    Nohria, Anju
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (08)
  • [3] TOXICITY OF CHEMOTHERAPY IN ELDERLY PATIENTS WITH COLORECTAL CANCER
    Siderov, Jim
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 94 - 94
  • [4] Toxicity of adjuvant chemotherapy in elderly breast cancer patients
    Rana, F.
    Garg, P.
    Guthrie, T.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 470 - 470
  • [5] Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
    Janssen-Heijnen, M. L. G.
    Maas, H. A. A. M.
    van de Schans, S. A. M.
    Coebergh, J. W. W.
    Groen, H. J. M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (04) : 821 - 826
  • [6] Predictors of Toxicity and Toxicity Profile of Adjuvant Chemotherapy in Elderly Breast Cancer Patients
    Garg, Praveen
    Rana, Fauzia
    Gupta, Ruchi
    Buzaianu, Elena M.
    Guthrie, Troy H.
    [J]. BREAST JOURNAL, 2009, 15 (04): : 404 - 408
  • [7] Reducing chemotherapy-associated toxicity in elderly cancer patients
    Zagonel, V
    Fratino, L
    Sacco, C
    Babare, R
    Spazzapan, S
    Gattei, V
    Improta, S
    Pinto, A
    [J]. CANCER TREATMENT REVIEWS, 1996, 22 (03) : 223 - 244
  • [8] Nutritional status and chemotherapy toxicity in elderly patients with gastrointestinal cancer
    Miraoui, D.
    Ghomari-Bezzar, S.
    Yekrou, D.
    Zeddam, F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S40 - S40
  • [9] Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients
    J. Feliu
    V. Heredia-Soto
    R. Gironés
    B. Jiménez-Munarriz
    J. Saldaña
    C. Guillén-Ponce
    M. J. Molina-Garrido
    [J]. Clinical and Translational Oncology, 2020, 22 : 457 - 467
  • [10] Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients
    Feliu, J.
    Heredia-Soto, V.
    Girones, R.
    Jimenez-Munarriz, B.
    Saldana, J.
    Guillen-Ponce, C.
    Molina-Garrido, M. J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (04): : 457 - 467